Bank of America says these stocks have more room to run, including one tech giant
Bank of America identifies stocks with growth potential, including Microsoft (MSFT), UBS (UBS), Expeditors International (EXPD), Timken (TKR), and First Horizon (FHN). Microsoft's AI strategy and Azure growth led to a price target increase to $600. Timken was upgraded to buy, with expectations of higher margins and earnings growth. First Horizon was praised for stability and leadership continuity. All stocks are up this year, with Timken leading at over 40%.
How this was made

The 30-second read
Why it matters
Analyst upgrades provide fresh buying signals for the highlighted companies.
Market read
The recommendations may generate modest buying interest in the named tickers.
What to watch
Potential macro headwinds or earnings volatility could temper the upside.
Background
Bank of America released a list of recommended stocks with upgrades and price target revisions.
Ticker impact
Bank of America raised Microsoft price target to $600, citing AI strategy and Azure growth.
Modest upside over next weeks if AI momentum continues.
Analyst upgrade with higher target provides a fresh catalyst for traders.
Timken upgraded to Buy from Hold, highlighted portfolio mix‑up and secular tailwinds.
Potential 5‑10% upside in the short term.
Analyst upgrade and growth thesis give a new actionable signal.
First Horizon given a Buy rating, emphasizing franchise stability and dividend yield.
Limited upside, likely 2‑4% over weeks.
Recommendation is new but the catalyst is modest.
UBS listed as a top idea in Bank of America’s Europe 1 list, citing growth in wealth and capital markets.
Small upside, 1‑3% in the near term.
Coverage is favorable but lacks a concrete quantitative catalyst.
Expeditors highlighted for organic growth and debt‑free balance sheet, seen as a long‑term winner.
Neutral to slight upside, 1‑2% over weeks.
Positive commentary without new quantitative data.
Market effects
Highlights AI‑driven growth themes across tech and industrials.
U.S. equities may see modest buying pressure from the upgrades.
Limited to U.S. listed names; no broader macro impact.
Counterpoint
Some investors may view the upgrades as overly optimistic given valuation levels.
Key entities
- Research FirmBank of America
Issuer of the stock recommendations.




